LEO Pharma has closed its acquisition of dersimelagon from Tanabe Pharma after the FDA accepted the drug's NDA for filing and granted Priority Review, with a PDUFA date expected by the end of February 2027.
|Articles|December 1, 2009
Paradigm shift: Link discovered between HPV, skin cancer
Author(s)Rebecca Bryant
Developments that link HPV to skin cancer could change the frontiers of medicine.
Advertisement
Key Points
"Research already shows that HPV causes many epidermal cancers.
"It's strongly linked to at least 95 percent of cervical cancers; 70 percent of anal cancers; 50 percent of vaginal, vulvar and penile cancers; and 20 percent of oropharyngeal cancers.1
More than 100 human papillomaviruses have been identified. They are numbered according to the order of their discovery. Scientists have recently subdivided the viruses into three subfamilies (alpha, beta and mu genera) based on genetic similarity.
In contrast, low-risk viruses - those associated with warts - are not.
Advertisement
Related to this article
Sol-Gel Technologies has completed patient follow-up in its pivotal phase 3 trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, with top-line results expected in late November 2026.
Two small clinical studies evaluated skincare and dermabrasion for changes in skin quality among individuals taking medical weight loss medications.
Two-year POETYK PsA-2 data showed sustained ACR and minimal disease activity responses with deucravacitinib and no new safety signals.
Faculty from the Cutaneous Oncology Workshop answer practical questions spanning skin cancer prevention, diagnosis, treatment, and follow-up.
Two new Neutrogena facial sunscreens incorporate bemotrizinol, the first new sunscreen active ingredient added to the US OTC monograph in decades.
Longer treatment duration was independently associated with VASI improvement, while publicly insured patients experienced higher topical JAK inhibitor denial rates.
Though convenient, SPF-infused cosmetics rarely deliver their labeled protection level in real-world use, underscoring the continued need for a dedicated broad-spectrum sunscreen as the foundation of any routine.
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Topical Solution Shows Long-Term Promise for Male Pattern Hair Loss
2
Neutrogena Launches New Sunscreens With Newly Permitted UV Filter Bemotrizinol
3
Maui Derm NP+PA Fall 2026 Day 2: GLP-1s, Inflammatory Disease, and Diagnostic Challenges
4
Dersimelagon NDA Accepted by FDA with Priority Review for EPP, XLP
5